Skye Bioscience

San Diego, United States

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

$50.3M raised

Jan 2024

Post-IPO Equity

Biotechnology Medical Pharmaceutical

Top Investors

Ally Bridge Group 5AM Ventures H. C. Wainwright & Co.Driehaus Capital Management TYLT Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Skye Bioscience

How much funding has Skye Bioscience raised?

Skye Bioscience has raised $50.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2024.

Who are Skye Bioscience's investors?

Skye Bioscience's investors include Ally Bridge Group, 5AM Ventures, H. C. Wainwright & Co., Driehaus Capital Management, TYLT Ventures.

Where is Skye Bioscience headquartered?

Skye Bioscience is headquartered in San Diego, United States.

What does Skye Bioscience do?

Skye Bioscience is a pharmaceutical company developing new therapeutic outcomes for diseases.

What stage is Skye Bioscience at?

Skye Bioscience is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2024.

MLA

"Skye Bioscience — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/skye-bioscience. Accessed July 2, 2026.

APA

VCBacked. (2024). Skye Bioscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/skye-bioscience

Wikipedia (cite web)

{{cite web |title=Skye Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/skye-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K